Una investigación liderada por el Instituto de Biomedicina de Sevilla y con la colaboración de la University of Texas Medical Branch (UTMB, Texas, USA), pone de manifiesto la eficacia y seguridad de...
Read more
El estudio ha identificado con una elevada sensibilidad la enfermedad mínima residual tras la cirugía, anticipando qué pacientes recaerán y quiénes podrán evitar tratamientos innecesarios
Read more
The Tekniker technology centre is currently helping to develop a system to serve as an alternative to traditional toxicological analysis methods. The solution follows European Commission recommendatio...
Read more
It has been developed an innovative CAR-T cell therapy targeting the CD30 protein (HSP-CAR30), which has shown high efficacy in patients with refractory CD30+ lymphoma
Read more
In a departure from typical “black-box” AI models, the new tool, CANYA, was designed to be able to explain its decisions, revealing the specific chemical patterns that drive or prevent harmful pro...
Read more
The study, published in the journal Environmental Health, revealed that girls with greater exposure to bisphenol A had a nearly three times greater risk of developing overweight or obesity.
Read more
Founded in 2022 as a spin-off from Vall d'Hebron Institut d'Oncologia, the University of Barcelona and Icrea, Oniria Therapeutics specialises in the development of targeted therapies to eliminate pers...
Read more
En un estudio en el que han participado investigadores de la Universidad Politécnica de Madrid, se ha desarrollado una novedosa estrategia que integra tecnologías sostenibles para optimizar la produ...
Read more
Un estudio colaborativo publicado recientemente en la revista British Journal of Pharmacology, ha mostrado la capacidad de la molécula MP-010, desarrollada por la spinoff del IIS Biogipuzkoa Miramoon...
Read more
A study led by CNIO researcher Nabil Djouder finds that the shortage of the p53 protein in animal models triggers colorectal tumours
Read more
Han descubierto que la espironolactona, un fármaco barato y aprobado para tratar la hipertensión, bloquea el inflamasoma NLRP1 y corrige los defectos en la formación de glóbulos rojos en la anemia...
Read more
The neurotechnology company INBRAIN Neuroelectronics, located in the Barcelona Science Park, has received a 4 million euro grant from the Spanish Ministry of Industry and Tourism through the PERTE Chi...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
